Omnicell
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for cli...
Latest News
8 days ago · zacks.com
Why Omnicell (OMCL) is a Top Momentum Stock for the Long-TermThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
12 days ago · zacks.com
Why Omnicell (OMCL) Might be Well Poised for a SurgeOmnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
12 days ago · zacks.com
OMCL vs. VEEV: Which Stock Should Value Investors Buy Now?Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Veeva Systems (VEEV). But which of these two companies is the best option for those looking for undervalued stocks?
12 days ago · zacks.com
Does Omnicell (OMCL) Have the Potential to Rally 40.83% as Wall Street Analysts Expect?The consensus price target hints at a 40.8% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
14 days ago · zacks.com
Why Omnicell (OMCL) is a Top Value Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
18 days ago · seekingalpha.com
Omnicell, Inc. (OMCL) Q3 2026 Earnings Call TranscriptOmnicell, Inc. ( OMCL ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants David Unger - Vice President of Investor Relations Randall Lipps - Founder, Executive Chairman & CEO Nnamdi Njoku - President & COO Baird Radford Conference Call Participants Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Jessica Tassan - Piper Sandler & Co., Research Division Allen Lutz - BofA Securities, Research Division David Larsen - BTIG, LLC, Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Gene Mannheimer William Sutherland - StoneX Financial, Inc., Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to the Omnicell Third Quarter 2026 Financial Results Call.
18 days ago · marketbeat.com
Omnicell Q3 Earnings Call HighlightsOmnicell NASDAQ: OMCL reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan XT automated dispensing hardware and remains on track for first-half 2027 general availability of its OmniSphere cloud platform.
19 days ago · zacks.com
Here's What Key Metrics Tell Us About Omnicell (OMCL) Q3 EarningsWhile the top- and bottom-line numbers for Omnicell (OMCL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
19 days ago · zacks.com
Omnicell (OMCL) Q3 Earnings and Revenues Top EstimatesOmnicell (OMCL) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.51 per share a year ago.
1 month ago · zacks.com
Is This the Right Time to Retain Omnicell Stock in Your Portfolio?OMCL raises its 2026 earnings outlook on cost discipline and efficiency, but rising memory costs and delayed Titan XT adoption pose challenges.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove OMCL